EU nod for new metastatic colorectal cancer combination

4th June 2020 Uncategorised 0

Pierre Fabre’s Braftovi in combination with Erbitux is the first licensed therapy for a specific subset of colorectal cancer patients

More: EU nod for new metastatic colorectal cancer combination
Source: News